Emcure Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : EMCURE
NIFTY : Nifty 500

About Company

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.</p>

Market Cap. ₹17,763 Cr.

52 Week - High/Low ₹1,580/889

P/E Ratio 98.68

P/B Ratio 9.18

Enterprise Value ₹18,418 Cr.

ROE % 8.59

RSI Value 37.67

EMA 50 1071.61

EMA 200 939.08

Net Profit 161 Cr.

Net Profit 3year growth -61.75 Cr.

Net Profit 3 year (back) 420 Cr.

Debt to Equity 0.73 %

EPS Growth TTM 30.32 %

Current Ratio 0.99 %

100 Day SMA 1,219 Rs.

200 Day SMA 1,298 Rs.

21 Day SMA 991 Rs.

50 Day SMA 1,056 Rs.

Book Value 102 Rs.

EV/EBITDA Ratio 37

QoQ EPS Growth -42 %

QoQ Operating Profit Growth -18 %

QoQ Sales Growth -7 %

Sales Latest Quarter 1,029 Cr.

YoY Sales Growth 16 %

Market Cap. ₹17,763 Cr.

52 Week - High/Low ₹1,580/889

P/E Ratio 35.51

P/B Ratio 6.02

Enterprise Value ₹18,903 Cr.

ROE % 19.45

RSI Value 37.67

EMA 50 1071.61

EMA 200 939.08

Net Profit 498 Cr.

Net Profit 3year growth 0.8 Cr.

Net Profit 3 year (back) 392 Cr.

Debt to Equity 0.71 %

EPS Growth TTM 24.65 %

Current Ratio 1.33 %

100 Day SMA 1,219 Rs.

200 Day SMA 1,298 Rs.

21 Day SMA 991 Rs.

50 Day SMA 1,056 Rs.

Book Value 156 Rs.

EV/EBITDA Ratio 17

QoQ EPS Growth -21 %

QoQ Operating Profit Growth -7 %

QoQ Sales Growth -2 %

Sales Latest Quarter 1,963 Cr.

YoY Sales Growth 18 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages